Duration of therapy for locally advanced pancreatic cancer: Does it matter?

INTRODUCTION: Evidence‐based recommendations on duration of multiagent systemic therapy for LAPC are lacking. Herein, we assess the impact of duration of combination systemic therapy on survival of patients with LAPC. METHODS: The National Cancer Database was interrogated to identify patients with u...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuli, Richard, David, John, Lobaugh, Stephanie, Zhang, Zhigang, O'Reilly, Eileen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333837/
https://www.ncbi.nlm.nih.gov/pubmed/32368871
http://dx.doi.org/10.1002/cam4.3081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333837/
https://www.ncbi.nlm.nih.gov/pubmed/32368871
http://dx.doi.org/10.1002/cam4.3081

Ejemplares similares